Ugt2b1 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA] CTD PMID:31150632 Ugt2b1 Rat (1->4)-beta-D-glucan multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UGT2B1 mRNA CTD PMID:36331819 Ugt2b1 Rat 1,2-dichloroethane decreases expression ISO Ugt2b1 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of UGT2B1 mRNA CTD PMID:28189721|PMID:28960355 Ugt2b1 Rat 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of UGT2B17 mRNA CTD PMID:27840820 Ugt2b1 Rat 1-naphthaleneacetic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 1-naphthaleneacetic acid CTD PMID:8302279 Ugt2b1 Rat 1-naphthol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 1-naphthol CTD PMID:8302279 Ugt2b1 Rat 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of UGT2B1 mRNA CTD PMID:30723492 Ugt2b1 Rat 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of UGT2B1 protein CTD PMID:12663690 Ugt2b1 Rat 17alpha-ethynylestradiol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ethinyl Estradiol CTD PMID:15921999 Ugt2b1 Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of UGT2B1 protein CTD PMID:12663690 Ugt2b1 Rat 17alpha-ethynylestradiol multiple interactions EXP 6480464 Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased activity of UGT2B1 protein]; Ursodeoxycholic more ... CTD PMID:12663690 Ugt2b1 Rat 17beta-estradiol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Estradiol CTD PMID:11836149 Ugt2b1 Rat 17beta-estradiol decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Estradiol results in decreased expression of UGT2B1 mRNA CTD PMID:39298647 Ugt2b1 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of UGT2B17 mRNA; Estradiol results in increased expression of UGT2B17 more ... CTD PMID:32145629 Ugt2b1 Rat 17beta-estradiol increases expression ISO UGT2B17 (Homo sapiens) 6480464 Estradiol results in increased expression of UGT2B17 mRNA CTD PMID:19619570 Ugt2b1 Rat 17beta-estradiol multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 Ugt2b1 Rat 17beta-hydroxy-5alpha-androstan-3-one increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Dihydrotestosterone CTD PMID:8798464 Ugt2b1 Rat 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of UGT2B1 mRNA CTD PMID:10036216 Ugt2b1 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of UGT2B17 mRNA CTD PMID:24878560 Ugt2b1 Rat 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of UGT2B1 mRNA; 2,2',4,4'-tetrabromodiphenyl ether results in increased expression more ... CTD PMID:31826744|PMID:32679240 Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B1 mRNA CTD PMID:19144771|PMID:19770486|PMID:22496397 Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] more ... CTD PMID:19619570|PMID:26159488 Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B1 mRNA; Tetrachlorodibenzodioxin results in decreased expression of UGT2B17 more ... CTD PMID:21215274|PMID:21724226 Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ugt2b1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of UGT2B1 mRNA CTD PMID:21570461 Ugt2b1 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Ugt2b1 (Mus musculus) 6480464 2,2',4,4',5-brominated diphenyl ether affects the expression of UGT2B1 mRNA CTD PMID:38648751 Ugt2b1 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2,6-dinitrotoluene affects the expression of UGT2B1 mRNA CTD PMID:21346803 Ugt2b1 Rat 2-Ethylhexanoic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-ethylhexanoic acid CTD PMID:8302279 Ugt2b1 Rat 2-Ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-ethylphenol CTD PMID:8302279 Ugt2b1 Rat 2-naphthol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-naphthol CTD PMID:8302279 Ugt2b1 Rat 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of UGT2B17 mRNA CTD PMID:23052194 Ugt2b1 Rat 3-Ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 3-ethylphenol CTD PMID:8302279 Ugt2b1 Rat 3-phenylpropionic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 3-phenylpropionic acid CTD PMID:8302279 Ugt2b1 Rat 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1,2-dithiol-3-thione results in increased expression of UGT2B1 mRNA CTD PMID:19162173 Ugt2b1 Rat 4,4'-sulfonyldiphenol affects expression ISO Ugt2b1 (Mus musculus) 6480464 bisphenol S affects the expression of UGT2B1 mRNA CTD PMID:39298647 Ugt2b1 Rat 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:31307193 Ugt2b1 Rat 4-ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-ethylphenol CTD PMID:8302279 Ugt2b1 Rat 4-hydroxyphenyl retinamide increases expression ISO Ugt2b1 (Mus musculus) 6480464 Fenretinide results in increased expression of UGT2B17 mRNA CTD PMID:28973697 Ugt2b1 Rat 4-methylcyclohexan-1-ol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-methylcyclohexanol CTD PMID:8302279 Ugt2b1 Rat 4-methylumbelliferone increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Hymecromone CTD PMID:8302279 Ugt2b1 Rat 4-methylumbelliferone increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Hymecromone CTD PMID:8798464 Ugt2b1 Rat 4-methylumbelliferone multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [UGT2B17 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of more ... CTD PMID:26875642|PMID:33290829 Ugt2b1 Rat 4-methylumbelliferone increases activity ISO UGT2B17 (Homo sapiens) 6480464 Hymecromone results in increased activity of UGT2B17 protein CTD PMID:26875642 Ugt2b1 Rat 4-methylumbelliferone increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of Hymecromone CTD PMID:33290829 Ugt2b1 Rat 4-methylumbelliferone beta-D-glucuronide multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [UGT2B17 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of more ... CTD PMID:33290829 Ugt2b1 Rat 4-tert-butylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of butylphen CTD PMID:8302279 Ugt2b1 Rat 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Ugt2b1 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of UGT2B1 mRNA CTD PMID:24780913 Ugt2b1 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of UGT2B1 mRNA CTD PMID:25825206 Ugt2b1 Rat 8-Br-cAMP increases expression ISO UGT2B17 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of UGT2B17 mRNA CTD PMID:22079614 Ugt2b1 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of UGT2B1 mRNA CTD PMID:31881176 Ugt2b1 Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of UGT2B17 mRNA CTD PMID:23052194|PMID:33354967 Ugt2b1 Rat aflatoxin B1 increases expression ISO UGT2B17 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of UGT2B17 mRNA CTD PMID:21641981 Ugt2b1 Rat aflatoxin B1 decreases methylation ISO UGT2B17 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of UGT2B17 gene CTD PMID:27153756 Ugt2b1 Rat aldrin increases expression ISO Ugt2b1 (Mus musculus) 6480464 Aldrin results in increased expression of UGT2B1 mRNA CTD PMID:18579281 Ugt2b1 Rat all-trans-retinoic acid decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Tretinoin results in decreased expression of UGT2B17 mRNA CTD PMID:23724009 Ugt2b1 Rat alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of UGT2B1 mRNA CTD PMID:16940010|PMID:17785943 Ugt2b1 Rat amentoflavone decreases activity ISO UGT2B17 (Homo sapiens) 6480464 amentoflavone results in decreased activity of UGT2B17 protein CTD PMID:29470958 Ugt2b1 Rat amiodarone affects expression EXP 6480464 Amiodarone affects the expression of UGT2B1 mRNA CTD PMID:18355885 Ugt2b1 Rat amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of UGT2B1 mRNA CTD PMID:18355885 Ugt2b1 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of UGT2B1 mRNA CTD PMID:16483693 Ugt2b1 Rat androstane-3,17-diol increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Androstane-3,17-diol CTD PMID:8798464 Ugt2b1 Rat androsterone increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Androsterone CTD PMID:8798464 Ugt2b1 Rat aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of UGT2B17 mRNA CTD PMID:23912714 Ugt2b1 Rat Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of UGT2B1 mRNA CTD PMID:18178546 Ugt2b1 Rat Aroclor 1254 affects expression ISO UGT2B17 (Homo sapiens) 6480464 Chlorodiphenyl (54% Chlorine) affects the expression of UGT2B17 mRNA CTD PMID:17851650 Ugt2b1 Rat arsenous acid decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of UGT2B17 mRNA CTD PMID:39716349 Ugt2b1 Rat atrazine affects expression EXP 6480464 Atrazine affects the expression of UGT2B17 mRNA CTD PMID:22285353 Ugt2b1 Rat benzene affects expression EXP 6480464 Benzene affects the expression of UGT2B1 mRNA CTD PMID:15878777 Ugt2b1 Rat benzo[a]pyrene increases expression ISO Ugt2b1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of UGT2B1 mRNA CTD PMID:19770486 Ugt2b1 Rat benzo[a]pyrene decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of UGT2B17 mRNA CTD PMID:32234424 Ugt2b1 Rat benzyl alcohol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Benzyl Alcohol CTD PMID:8302279 Ugt2b1 Rat bezafibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Bezafibrate CTD PMID:8302279 Ugt2b1 Rat bicalutamide decreases expression ISO UGT2B17 (Homo sapiens) 6480464 bicalutamide results in decreased expression of UGT2B17 mRNA CTD PMID:15638997 Ugt2b1 Rat biphenyl-4-ol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-phenylphenol CTD PMID:11836149|PMID:12153725|PMID:8302279 Ugt2b1 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of UGT2B1 mRNA CTD PMID:19850644 Ugt2b1 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of UGT2B1 mRNA] CTD PMID:19850644 Ugt2b1 Rat bisphenol A increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of bisphenol A CTD PMID:10333482|PMID:11836149|PMID:12153725 Ugt2b1 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UGT2B1 mRNA; bisphenol A results in increased expression more ... CTD PMID:29960846|PMID:32145629 Ugt2b1 Rat bisphenol A increases expression ISO Ugt2b1 (Mus musculus) 6480464 bisphenol A results in increased expression of UGT2B1 mRNA CTD PMID:30245210 Ugt2b1 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UGT2B1 mRNA CTD PMID:30903817 Ugt2b1 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UGT2B1 mRNA; bisphenol A results in decreased expression more ... CTD PMID:12230427|PMID:25181051 Ugt2b1 Rat bisphenol AF multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of and results in decreased activity of bisphenol AF CTD PMID:24349450 Ugt2b1 Rat bisphenol AF increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of bisphenol AF CTD PMID:30408883 Ugt2b1 Rat bisphenol F increases expression ISO Ugt2b1 (Mus musculus) 6480464 bisphenol F results in increased expression of UGT2B1 mRNA CTD PMID:38685157 Ugt2b1 Rat bromuconazole increases expression EXP 6480464 bromuconazole results in increased expression of UGT2B1 mRNA CTD PMID:33789219 Ugt2b1 Rat buta-1,3-diene decreases expression ISO Ugt2b1 (Mus musculus) 6480464 1,3-butadiene results in decreased expression of UGT2B1 mRNA CTD PMID:29038090 Ugt2b1 Rat butylated hydroxyanisole decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Butylated Hydroxyanisole results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 Ugt2b1 Rat cadmium acetate affects expression EXP 6480464 cadmium acetate affects the expression of UGT2B17 mRNA CTD PMID:16249259 Ugt2b1 Rat cadmium atom multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of UGT2B1 more ... CTD PMID:37236586 Ugt2b1 Rat cadmium dichloride multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of UGT2B1 more ... CTD PMID:37236586 Ugt2b1 Rat calcitriol decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Calcitriol results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 Ugt2b1 Rat calcitriol multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 Ugt2b1 Rat carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of UGT2B1 mRNA CTD PMID:17381134 Ugt2b1 Rat carbon nanotube decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Nanotubes, Carbon analog results in decreased expression of UGT2B1 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25620056 Ugt2b1 Rat chloramphenicol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Chloramphenicol CTD PMID:8302279 Ugt2b1 Rat chlorogenic acid decreases activity ISO UGT2B17 (Homo sapiens) 6480464 Chlorogenic Acid results in decreased activity of UGT2B17 protein CTD PMID:35868516 Ugt2b1 Rat chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of more ... CTD PMID:30744511 Ugt2b1 Rat ciprofibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of ciprofibrate CTD PMID:8302279 Ugt2b1 Rat cis-caffeic acid decreases activity ISO UGT2B17 (Homo sapiens) 6480464 caffeic acid results in decreased activity of UGT2B17 protein CTD PMID:35868516 Ugt2b1 Rat cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of UGT2B17 protein CTD PMID:22023808 Ugt2b1 Rat clofibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Clofibrate CTD PMID:8302279 Ugt2b1 Rat clofibrate decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Clofibrate results in decreased expression of UGT2B1 mRNA CTD PMID:22496397 Ugt2b1 Rat clofibrate multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [Clofibrate co-treated with PPARA protein mutant form] results in increased expression of UGT2B1 mRNA CTD PMID:22496397 Ugt2b1 Rat clofibric acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Clofibric Acid CTD PMID:8302279 Ugt2b1 Rat clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UGT2B1 mRNA CTD PMID:17602206 Ugt2b1 Rat clomipramine affects expression EXP 6480464 Clomipramine affects the expression of UGT2B1 mRNA CTD PMID:18355885 Ugt2b1 Rat cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of UGT2B1 mRNA CTD PMID:10476907 Ugt2b1 Rat cyclosporin A decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Cyclosporine results in decreased expression of UGT2B1 mRNA CTD PMID:19770486 Ugt2b1 Rat cyclosporin A decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of UGT2B17 mRNA CTD PMID:27989131 Ugt2b1 Rat cylindrospermopsin decreases expression ISO UGT2B17 (Homo sapiens) 6480464 cylindrospermopsin results in decreased expression of UGT2B17 mRNA CTD PMID:30905859 Ugt2b1 Rat cylindrospermopsin decreases expression ISO Ugt2b1 (Mus musculus) 6480464 cylindrospermopsin results in decreased expression of UGT2B1 mRNA CTD PMID:20936652 Ugt2b1 Rat cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA CTD PMID:29038839 Ugt2b1 Rat cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of UGT2B1 mRNA CTD PMID:29038839 Ugt2b1 Rat daidzein increases expression ISO UGT2B17 (Homo sapiens) 6480464 daidzein results in increased expression of UGT2B17 mRNA CTD PMID:16865672 Ugt2b1 Rat DDE multiple interactions EXP 6480464 [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of UGT2B17 mRNA CTD PMID:24878560 Ugt2b1 Rat decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of UGT2B1 mRNA CTD PMID:32679240 Ugt2b1 Rat dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of UGT2B1 mRNA; Dexamethasone results in increased expression of UGT2B17 more ... CTD PMID:11328961|PMID:15102944|PMID:20832446|PMID:21146967|PMID:39909212 Ugt2b1 Rat dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of UGT2B1 mRNA CTD PMID:15102944 Ugt2b1 Rat diarsenic trioxide decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of UGT2B17 mRNA CTD PMID:39716349 Ugt2b1 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of UGT2B1 mRNA CTD PMID:15901914 Ugt2b1 Rat dichloroacetic acid decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of UGT2B1 mRNA CTD PMID:28962523 Ugt2b1 Rat diclofenac increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of Diclofenac CTD PMID:15843492|PMID:22265884 Ugt2b1 Rat diethylstilbestrol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Diethylstilbestrol CTD PMID:11836149 Ugt2b1 Rat diethylstilbestrol increases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of UGT2B1 mRNA CTD PMID:20163289 Ugt2b1 Rat Diosbulbin B decreases expression ISO Ugt2b1 (Mus musculus) 6480464 diosbulbin B results in decreased expression of UGT2B1 mRNA CTD PMID:39368342 Ugt2b1 Rat diquat decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Diquat results in decreased expression of UGT2B17 protein CTD PMID:36851058 Ugt2b1 Rat doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of UGT2B1 mRNA CTD PMID:26335259 Ugt2b1 Rat doxorubicin multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] CTD PMID:26335259 Ugt2b1 Rat elemental selenium increases expression EXP 6480464 Selenium deficiency results in increased expression of UGT2B1 mRNA CTD PMID:11444866 Ugt2b1 Rat endosulfan multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:26159488 Ugt2b1 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of UGT2B1 mRNA CTD PMID:29391264 Ugt2b1 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of UGT2B17 mRNA CTD PMID:29391264 Ugt2b1 Rat epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA CTD PMID:29038839 Ugt2b1 Rat epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of UGT2B1 mRNA CTD PMID:29038839 Ugt2b1 Rat equol increases expression ISO UGT2B17 (Homo sapiens) 6480464 Equol results in increased expression of UGT2B17 mRNA CTD PMID:16865672 Ugt2b1 Rat ethyl methanesulfonate increases expression ISO UGT2B17 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of UGT2B17 mRNA CTD PMID:23649840 Ugt2b1 Rat eugenol increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Eugenol CTD PMID:8798464 Ugt2b1 Rat felbamate increases expression EXP 6480464 felbamate results in increased expression of UGT2B1 mRNA CTD PMID:17381134 Ugt2b1 Rat fipronil increases expression ISO Ugt2b1 (Mus musculus) 6480464 fipronil results in increased expression of UGT2B1 mRNA CTD PMID:23962444 Ugt2b1 Rat fipronil increases expression EXP 6480464 fipronil results in increased expression of UGT2B1 mRNA CTD PMID:23962444 Ugt2b1 Rat fluconazole increases expression EXP 6480464 Fluconazole results in increased expression of UGT2B1 mRNA CTD PMID:16643972 Ugt2b1 Rat flumequine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 flumequine results in decreased expression of UGT2B1 mRNA CTD PMID:23681119 Ugt2b1 Rat flumequine multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in decreased expression of UGT2B1 mRNA CTD PMID:23681119 Ugt2b1 Rat flurbiprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Flurbiprofen CTD PMID:8302279 Ugt2b1 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat formaldehyde increases expression ISO UGT2B17 (Homo sapiens) 6480464 Formaldehyde results in increased expression of UGT2B17 mRNA CTD PMID:23649840 Ugt2b1 Rat fumonisin B1 multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA; more ... CTD PMID:30448865 Ugt2b1 Rat gabapentin increases expression EXP 6480464 gabapentin results in increased expression of UGT2B1 mRNA CTD PMID:17381134 Ugt2b1 Rat genistein multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 Genistein inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] CTD PMID:23333575 Ugt2b1 Rat genistein increases expression ISO UGT2B17 (Homo sapiens) 6480464 Genistein results in increased expression of UGT2B17 mRNA CTD PMID:16865672 Ugt2b1 Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of UGT2B1 mRNA CTD PMID:15345336 Ugt2b1 Rat hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of UGT2B1 mRNA CTD PMID:15159207 Ugt2b1 Rat hydratropic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of hydratropic acid CTD PMID:8302279 Ugt2b1 Rat ibuprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ibuprofen CTD PMID:8302279 Ugt2b1 Rat imipramine affects expression EXP 6480464 Imipramine affects the expression of UGT2B1 mRNA CTD PMID:18355885 Ugt2b1 Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of UGT2B1 mRNA CTD PMID:21396975 Ugt2b1 Rat indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT2B17 mRNA CTD PMID:22129741 Ugt2b1 Rat iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of UGT2B17 mRNA CTD PMID:16629162 Ugt2b1 Rat iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of UGT2B17 mRNA CTD PMID:16629162 Ugt2b1 Rat ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of UGT2B1 mRNA CTD PMID:18355885 Ugt2b1 Rat ketoprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ketoprofen CTD PMID:8302279 Ugt2b1 Rat L-ascorbic acid multiple interactions EXP 6480464 UGT2B17 protein affects the reaction [Phenobarbital results in increased abundance of Ascorbic Acid] CTD PMID:8263600 Ugt2b1 Rat lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Ugt2b1 Rat Lasiocarpine increases expression EXP 6480464 lasiocarpine results in increased expression of UGT2B17 mRNA CTD PMID:32419051 Ugt2b1 Rat Licochalcone A multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT2B17 protein] CTD PMID:26875642 Ugt2b1 Rat lipopolysaccharide decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of UGT2B1 mRNA CTD PMID:27339419 Ugt2b1 Rat lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of UGT2B17 mRNA CTD PMID:21311750 Ugt2b1 Rat lorcaserin multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased carbamoylation of and results in increased glucuronidation of lorcaserin CTD PMID:22259019 Ugt2b1 Rat MeIQx multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in decreased expression of UGT2B1 mRNA CTD PMID:23681119 Ugt2b1 Rat methyl methanesulfonate increases expression ISO UGT2B17 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of UGT2B17 mRNA CTD PMID:23649840 Ugt2b1 Rat methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of more ... CTD PMID:30744511 Ugt2b1 Rat Mitotane increases expression EXP 6480464 Mitotane results in increased expression of UGT2B1 mRNA CTD PMID:10036216 Ugt2b1 Rat Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of UGT2B1 mRNA CTD PMID:21515302 Ugt2b1 Rat N-nitrosodiethylamine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of UGT2B1 mRNA CTD PMID:24535843 Ugt2b1 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UGT2B1 mRNA; [Diethylnitrosamine co-treated with Piperonyl more ... CTD PMID:17602206|PMID:18648771|PMID:22129741 Ugt2b1 Rat N-nitrosodiethylamine multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of UGT2B1 mRNA] CTD PMID:17942915 Ugt2b1 Rat N-nitrosodiethylamine increases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of UGT2B1 mRNA CTD PMID:17942915 Ugt2b1 Rat N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of UGT2B1 mRNA CTD PMID:22037397 Ugt2b1 Rat naproxen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Naproxen CTD PMID:8302279 Ugt2b1 Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat nelfinavir increases expression EXP 6480464 Nelfinavir results in increased expression of UGT2B1 mRNA CTD PMID:16408618 Ugt2b1 Rat nimesulide increases expression EXP 6480464 nimesulide results in increased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat Nonylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of nonylphenol CTD PMID:11836149 Ugt2b1 Rat O-methyleugenol decreases expression ISO UGT2B17 (Homo sapiens) 6480464 methyleugenol results in decreased expression of UGT2B17 mRNA CTD PMID:32234424 Ugt2b1 Rat okadaic acid decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of UGT2B17 mRNA CTD PMID:38832940 Ugt2b1 Rat oltipraz decreases expression ISO Ugt2b1 (Mus musculus) 6480464 oltipraz results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 Ugt2b1 Rat oltipraz increases expression EXP 6480464 oltipraz results in increased expression of UGT2B1 mRNA CTD PMID:18418891 Ugt2b1 Rat oltipraz multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [oltipraz co-treated with NFE2L2 protein mutant form] results in decreased expression of UGT2B1 mRNA CTD PMID:22496397 Ugt2b1 Rat omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Ugt2b1 Rat orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of UGT2B1 mRNA CTD PMID:23665939 Ugt2b1 Rat p-cresol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-cresol CTD PMID:8302279 Ugt2b1 Rat p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of UGT2B1 mRNA CTD PMID:27638505 Ugt2b1 Rat pantoprazole increases expression EXP 6480464 pantoprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Ugt2b1 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of UGT2B1 mRNA CTD PMID:17126469|PMID:18246545|PMID:32479839 Ugt2b1 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of UGT2B1 mRNA CTD PMID:30723492 Ugt2b1 Rat paracetamol multiple interactions EXP 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 Ugt2b1 Rat paracetamol multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 Genistein inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA]; hyperoside inhibits the more ... CTD PMID:23333575|PMID:26772156|PMID:29246445 Ugt2b1 Rat paracetamol decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Acetaminophen results in decreased expression of UGT2B1 mRNA CTD PMID:23333575|PMID:26772156|PMID:29246445 Ugt2b1 Rat paracetamol affects expression ISO Ugt2b1 (Mus musculus) 6480464 Acetaminophen affects the expression of UGT2B1 mRNA CTD PMID:17562736 Ugt2b1 Rat pectolinarigenin increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of pectolinarigenin CTD PMID:37797876 Ugt2b1 Rat perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of UGT2B1 mRNA CTD PMID:19162173 Ugt2b1 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UGT2B1 mRNA CTD PMID:36331819 Ugt2b1 Rat perfluorooctane-1-sulfonic acid affects expression ISO Ugt2b1 (Mus musculus) 6480464 perfluorooctane sulfonic acid affects the expression of UGT2B1 mRNA CTD PMID:19429403 Ugt2b1 Rat perfluorooctanoic acid decreases expression ISO Ugt2b1 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of UGT2B1 mRNA; perfluorooctanoic acid results in decreased expression more ... CTD PMID:17681415|PMID:18467677 Ugt2b1 Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of UGT2B17 mRNA CTD PMID:28511854 Ugt2b1 Rat perfluorooctanoic acid affects expression ISO Ugt2b1 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of UGT2B1 mRNA CTD PMID:19429403 Ugt2b1 Rat perfluorooctanoic acid multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of UGT2B17 mRNA] CTD PMID:18467677 Ugt2b1 Rat phenformin increases expression EXP 6480464 Phenformin results in increased expression of UGT2B1 mRNA CTD PMID:31324951 Ugt2b1 Rat phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of UGT2B1 mRNA; Phenobarbital results in increased expression of UGT2B1 more ... CTD PMID:10036216|PMID:10476907|PMID:11328961|PMID:12832660|PMID:16408618|PMID:16940010|PMID:17381134|PMID:17967931|PMID:19162173|PMID:22037397|PMID:24090815|PMID:28520973|PMID:39909212|PMID:8263600 Ugt2b1 Rat phenobarbital increases expression ISO Ugt2b1 (Mus musculus) 6480464 Phenobarbital results in increased expression of UGT2B1 mRNA CTD PMID:19760798 Ugt2b1 Rat phenobarbital decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Phenobarbital results in decreased expression of UGT2B17 mRNA CTD PMID:19084549 Ugt2b1 Rat phenobarbital multiple interactions EXP 6480464 UGT2B17 protein affects the reaction [Phenobarbital results in increased abundance of Ascorbic Acid] CTD PMID:8263600 Ugt2b1 Rat phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of UGT2B17 protein CTD PMID:8263600 Ugt2b1 Rat phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of UGT2B1 mRNA CTD PMID:17381134 Ugt2b1 Rat phloretin decreases activity ISO UGT2B17 (Homo sapiens) 6480464 Phloretin results in decreased activity of UGT2B17 protein CTD PMID:35868516 Ugt2b1 Rat phlorizin decreases activity ISO UGT2B17 (Homo sapiens) 6480464 Phlorhizin results in decreased activity of UGT2B17 protein CTD PMID:35868516 Ugt2b1 Rat piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of UGT2B1 mRNA; Piperonyl Butoxide results in increased expression more ... CTD PMID:17498859|PMID:18544911|PMID:22484513 Ugt2b1 Rat piperonyl butoxide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of UGT2B17 mRNA; Triterpenes promotes the more ... CTD PMID:18544911|PMID:18648771 Ugt2b1 Rat pirinixic acid multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of UGT2B17 mRNA] CTD PMID:18467677 Ugt2b1 Rat pirinixic acid decreases expression ISO Ugt2b1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of UGT2B1 mRNA; pirinixic acid results in decreased expression more ... CTD PMID:18467677|PMID:20936131|PMID:23811191 Ugt2b1 Rat pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of UGT2B1 mRNA; pirinixic acid results in decreased expression more ... CTD PMID:19162173|PMID:22484513 Ugt2b1 Rat pirprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of pirprofen CTD PMID:8302279 Ugt2b1 Rat poly(I:C) decreases expression EXP 6480464 Poly I-C results in decreased expression of UGT2B1 mRNA CTD PMID:23939143 Ugt2b1 Rat pravastatin decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Pravastatin results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 Ugt2b1 Rat pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 Ugt2b1 Rat pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of UGT2B1 mRNA CTD PMID:19162173|PMID:22037397|PMID:39069214 Ugt2b1 Rat prochloraz increases expression EXP 6480464 prochloraz results in increased expression of UGT2B1 mRNA CTD PMID:29038839 Ugt2b1 Rat propiconazole increases expression ISO Ugt2b1 (Mus musculus) 6480464 propiconazole results in increased expression of UGT2B1 mRNA CTD PMID:21278054 Ugt2b1 Rat propiconazole increases expression EXP 6480464 propiconazole results in increased expression of UGT2B1 mRNA; propiconazole results in increased expression of UGT2B17 more ... CTD PMID:16643972|PMID:17178689|PMID:19409404|PMID:19423681 Ugt2b1 Rat quercetin 3-O-beta-D-galactopyranoside multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] CTD PMID:26772156 Ugt2b1 Rat quercetin 3-O-beta-D-galactopyranoside increases expression ISO Ugt2b1 (Mus musculus) 6480464 hyperoside results in increased expression of UGT2B1 mRNA CTD PMID:26772156 Ugt2b1 Rat quinolines increases expression EXP 6480464 Quinolines results in increased expression of UGT2B1 mRNA CTD PMID:9176741 Ugt2b1 Rat rabeprazole increases expression EXP 6480464 Rabeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Ugt2b1 Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of UGT2B1 mRNA CTD PMID:28374803 Ugt2b1 Rat selenium atom increases expression EXP 6480464 Selenium deficiency results in increased expression of UGT2B1 mRNA CTD PMID:11444866 Ugt2b1 Rat senecionine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 senecionine results in decreased expression of UGT2B1 mRNA CTD PMID:31606820 Ugt2b1 Rat sodium arsenite increases expression ISO UGT2B17 (Homo sapiens) 6480464 sodium arsenite results in increased expression of UGT2B17 mRNA CTD PMID:38568856 Ugt2b1 Rat tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of UGT2B1 mRNA CTD PMID:8706011 Ugt2b1 Rat taurine multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA]; more ... CTD PMID:26335259 Ugt2b1 Rat tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of UGT2B1 protein CTD PMID:24090815 Ugt2b1 Rat Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of UGT2B1 mRNA CTD PMID:21515302 Ugt2b1 Rat testosterone increases expression ISO Ugt2b1 (Mus musculus) 6480464 Testosterone results in increased expression of UGT2B1 mRNA CTD PMID:20844152 Ugt2b1 Rat testosterone multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 Ugt2b1 Rat testosterone decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Testosterone results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 Ugt2b1 Rat testosterone increases expression ISO UGT2B17 (Homo sapiens) 6480464 Testosterone results in increased expression of UGT2B17 mRNA CTD PMID:21880219 Ugt2b1 Rat testosterone increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Testosterone CTD PMID:8798464 Ugt2b1 Rat testosterone increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Testosterone CTD PMID:11836149|PMID:8302279 Ugt2b1 Rat Testosterone propionate decreases expression EXP 6480464 Testosterone Propionate results in decreased expression of UGT2B1 mRNA CTD PMID:16829708 Ugt2b1 Rat tetrachloromethane decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of UGT2B1 mRNA CTD PMID:27339419|PMID:29987408|PMID:31919559 Ugt2b1 Rat tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of UGT2B1 mRNA CTD PMID:32380060 Ugt2b1 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA] CTD PMID:31150632 Ugt2b1 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of UGT2B1 mRNA; Carbon Tetrachloride results in decreased expression more ... CTD PMID:31150632 Ugt2b1 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of UGT2B17 mRNA CTD PMID:37008694 Ugt2b1 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of UGT2B17 mRNA CTD PMID:34492290 Ugt2b1 Rat trans-caffeic acid decreases activity ISO UGT2B17 (Homo sapiens) 6480464 caffeic acid results in decreased activity of UGT2B17 protein CTD PMID:35868516 Ugt2b1 Rat triadimefon increases expression EXP 6480464 triadimefon results in increased expression of UGT2B1 mRNA; triadimefon results in increased expression of UGT2B17 more ... CTD PMID:16643972|PMID:17178689|PMID:19409404|PMID:19423681 Ugt2b1 Rat trichloroethene decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of UGT2B1 mRNA CTD PMID:25549359 Ugt2b1 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of UGT2B17 mRNA CTD PMID:33387578 Ugt2b1 Rat trifluralin increases expression EXP 6480464 Trifluralin results in increased expression of UGT2B1 mRNA CTD PMID:18582544 Ugt2b1 Rat triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of UGT2B1 mRNA CTD PMID:30589522 Ugt2b1 Rat trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat uranium atom multiple interactions EXP 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 Ugt2b1 Rat ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased activity of UGT2B1 protein]; Ursodeoxycholic more ... CTD PMID:12663690 Ugt2b1 Rat ursodeoxycholic acid increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of Ursodeoxycholic Acid CTD PMID:31299240 Ugt2b1 Rat valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat valproic acid decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of UGT2B17 mRNA CTD PMID:29154799 Ugt2b1 Rat valproic acid decreases methylation ISO UGT2B17 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of UGT2B17 gene CTD PMID:29154799 Ugt2b1 Rat valproic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Valproic Acid CTD PMID:8302279 Ugt2b1 Rat valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of UGT2B1 mRNA CTD PMID:17381134 Ugt2b1 Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of UGT2B17 mRNA CTD PMID:22285353 Ugt2b1 Rat vorinostat increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of vorinostat CTD PMID:25393417 Ugt2b1 Rat vorinostat multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Warfarin binds to and results in decreased activity of UGT2B17 protein] which results in decreased more ... CTD PMID:25393417 Ugt2b1 Rat warfarin multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Warfarin binds to and results in decreased activity of UGT2B17 protein] which results in decreased more ... CTD PMID:25393417 Ugt2b1 Rat zaragozic acid A decreases expression ISO Ugt2b1 (Mus musculus) 6480464 squalestatin 1 results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 Ugt2b1 Rat zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of UGT2B1 mRNA CTD PMID:27225895 Ugt2b1 Rat zidovudine increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Zidovudine CTD PMID:8302279 Ugt2b1 Rat zinc acetate multiple interactions EXP 6480464 [Taurine co-treated with Zinc Acetate] results in increased expression of UGT2B1 mRNA CTD PMID:26335259 Ugt2b1 Rat zinc atom multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA]; more ... CTD PMID:26335259 Ugt2b1 Rat zinc(0) multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA]; more ... CTD PMID:26335259